on-Alcoholic Fatty Liver Disease in children: determining the prevalence of liver fibrosis using FibroScan®
- Conditions
- fatty liverhepatic steatosis10019654
- Registration Number
- NL-OMON55751
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 604
• Age 8 - 18 years
• Obesity (BMI >= 95th percentile) or overweight (BMI >= 85th and < 94th
percentile) with one of the following additional risk factors: central
adiposity, insulin resistance, prediabetes or diabetes, dyslipidemia, sleep
apnea, or family history of NAFLD/NASH.
• Age > 18 years
• Other liver disease (viral/autoimmune hepatitis, M. Wilson, haemochromatosis,
alfa1-antitrypsine deficiency)
• Metabolic disease (beta-oxidation defects, urea cyclus defects)
• Alcohol consumption > 140 g/week
• Use of steatogenic medication
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method